BioNTech and US drugmaker Pfizer will supply 12.5 million doses of their COVID-19 vaccine to the European Union by the end of the year, the German company said on Tuesday.
For more coronavirus news, visit our dedicated page.
That is more than half the 20 million doses expected to be delivered to the United States before the end of the year, BioNTech’s chief business officer, Sean Marett, told a briefing.
For all the latest headlines follow our Google News channel online or via the app
With two shots administered three weeks apart, the EU deliveries would be enough to vaccinate 6.25 million people as the companies gear up to deliver the first shots following regulatory approval on Monday.
Germany extends ban on UK, S. Africa arrivals until Jan 6 over new coronavirus strain
The 27 EU member states that want shots will receive them within five days, Marett told a briefing.
The German biotech company plans to start production in February at its site in Marburg, Germany, chief financial officer Sierk Poetting said in the same briefing.
It has said previously the facility, which it bought in September, would eventually have an annual production capacity up to 750 million doses.
- Coronavirus: France gives front line COVID-19 workers citizenship
- WHO calls meet on new coronavirus strain, European head urges more preventive steps
- Germany extends ban on UK, S. Africa arrivals until Jan 6 over new coronavirus strain
- Coronavirus: BioNTech says mutation-beating vaccine can be ready in six weeks
- Coronavirus: US may require passengers from UK to provide negative PCR test
- New strain of coronavirus not detected in Saudi Arabia ‘yet’: Health ministry
- Coronavirus: France expects national COVID-19 vaccine approval by December 26